相关实验视频

Updated: Jun 3, 2025

Neurogenesis Using P19 Embryonal Carcinoma Cells

Neurogenesis Using P19 Embryonal Carcinoma Cells

Published on: April 27, 2019

中枢神经系统瘤-胚胎瘤类型与神经内分泌分化

Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu

Clinical nuclear medicine

|January 9, 2025

概括

中枢神经系统胚胎瘤 (CET) 缺乏明确的标志物,限制了治疗. 在CET患者中,PET/CT成像确定了体静止素受体 (SSTR) 表达,这表明受体放射性核酸治疗是可行的选择.

科学领域:

神经瘤学神经瘤学
核医学是一种核医学.
放射学放射学是一门学科.

背景情况:

中枢神经系统胚胎瘤 (CET) 是罕见的,缺乏特定的遗传标记物和有效的治疗方法.
对于CET的传统疗法通常会导致显著的不良事件.
使用分子成像的治疗方法可以个性化CET治疗.

研究的目的:

研究PET/CT成像用于识别CET患者向受体表达的潜力.
评估体静止素受体 (SSTR) 和前列腺特异性膜抗原 (PSMA) 表达用于指导治疗的实用性.
介绍一个案例研究,说明在CET管理中应用theranostics.

主要方法:

使用正子发射断层扫描/计算机断层扫描 (PET/CT) 成像.
评估了体静止素受体 (SSTR) 和前列腺特异性膜抗原 (PSMA) 的表达水平.
与临床诊断和潜在的治疗策略相关联的成像发现.

主要成果:

一名56岁的女性患者被诊断患有CET,出现头痛和视力丧失.
PET/CT成像显示患者CET中的高SSTR表达.
这一发现表明了受体放射性核素治疗 (PRRT) 的潜力.

结论:

PET/CT成像可以识别CET中的特定受体表达.
高SSTR表达表明PRRT作为选择CET患者的有前途的治疗选择.
治疗神经系统提供了一个个性化的方法来管理罕见的中枢神经系统瘤,如CETs.

更多相关视频

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery

An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery

Published on: August 23, 2016

相关概念视频

Neurulation

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...